Mesa Laboratories (NASDAQ:MLAB) Shares Cross Above Two Hundred Day Moving Average of $99.57

Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $99.57 and traded as high as $103.32. Mesa Laboratories shares last traded at $99.62, with a volume of 31,078 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Evercore ISI lifted their price objective on shares of Mesa Laboratories from $124.00 to $130.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th.

Mesa Laboratories Stock Up 1.1 %

The company has a market capitalization of $542.99 million, a PE ratio of 592.62 and a beta of 0.83. The company has a current ratio of 2.68, a quick ratio of 1.86 and a debt-to-equity ratio of 0.58. The firm has a 50 day simple moving average of $104.47 and a two-hundred day simple moving average of $99.57.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings data on Monday, February 5th. The medical instruments supplier reported $1.46 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.01). The firm had revenue of $53.47 million during the quarter, compared to analysts’ expectations of $54.90 million. Mesa Laboratories had a net margin of 0.45% and a return on equity of 7.41%. Research analysts expect that Mesa Laboratories, Inc. will post 6.15 EPS for the current year.

Mesa Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Friday, May 31st will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date is Friday, May 31st. Mesa Laboratories’s dividend payout ratio (DPR) is 376.49%.

Institutional Investors Weigh In On Mesa Laboratories

Institutional investors have recently made changes to their positions in the stock. Point72 Hong Kong Ltd acquired a new stake in shares of Mesa Laboratories in the first quarter valued at about $27,000. Quadrant Capital Group LLC boosted its stake in shares of Mesa Laboratories by 515.6% during the 4th quarter. Quadrant Capital Group LLC now owns 277 shares of the medical instruments supplier’s stock worth $29,000 after acquiring an additional 232 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in shares of Mesa Laboratories during the 2nd quarter worth approximately $41,000. Tower Research Capital LLC TRC grew its holdings in shares of Mesa Laboratories by 235.2% in the 1st quarter. Tower Research Capital LLC TRC now owns 295 shares of the medical instruments supplier’s stock worth $52,000 after acquiring an additional 207 shares during the period. Finally, Amundi purchased a new position in Mesa Laboratories in the 4th quarter valued at approximately $102,000. 90.60% of the stock is currently owned by hedge funds and other institutional investors.

About Mesa Laboratories

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.